Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Silanediol Enabled Drug Discovery
Association analysis of rare variants with sequencing data
Functional Outcomes After Major Surgery in Nursing Home Residents
Cellular Response to cMet Endocytosis
Neural Systems for Reading in Medulloblastoma Survivors
Recently added grants:
Probing cytosolic nucleic acid sensing pathways in cancer
Fluid shear stress mechanotransduction at endothelial cell-cell junctions
Functional dissection of fibronectin type 3 domains of SORL1 in Alzheimers disease associated microglia
Kidney PCSK9 in nephrotic syndrome
Developmental underpinnings of substantia nigra vulnerability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-003
Application #
7329487
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant